REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 8th, 2021 • Jaguar Health, Inc. • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 7, 2021 (the “Execution Date”), is entered into by and between JAGUAR HEALTH, INC., a Delaware corporation (the “Company”), and OASIS CAPITAL, LLC, a Puerto Rico limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain First Amendment to the Equity Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Amendment”).
COMMON STOCK PURCHASE WARRANT JAGUAR HEALTH, INC.Common Stock Purchase Warrant • April 8th, 2021 • Jaguar Health, Inc. • Pharmaceutical preparations • New York
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Oasis Capital, LLC, a Puerto Rico limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Jaguar Health, Inc., a Delaware corporation (the “Company”), up to 100,000 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the Issuance Date in connection with that certain First Amendment to the Equity Line Purchase Agreement, dated April 7, 2021, by and between the Company and the Holder (the “Agreement”).
Certain information marked as [****] has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.Jaguar Health, Inc. • April 8th, 2021 • Pharmaceutical preparations • California
This Lease is made and entered into as of March 25, 2021, by and between M & E, LLC, a California Limited Liability Company (“Landlord”), and Jaguar Health, Inc. a Delaware corporation (“Tenant”), who agree as follows:
First Amendment to The EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • April 8th, 2021 • Jaguar Health, Inc. • Pharmaceutical preparations • New York
This First Amendment (this “Amendment”), dated April 7, 2021, to the Equity Purchase Agreement, dated March 24, 2020 (the “Agreement”), is made by and between Jaguar Health, Inc., a Delaware corporation (the “Company”), and Oasis Capital, LLC, a Puerto Rico limited liability company (the “Investor”). The Company and the Investor are sometimes referred to individually as a “Party” and collectively as the “Parties.”
